ERBB2 and urothelial carcinoma: Ching et al. [22] evaluated the particularly aggressive micropapillary variant of urothelial carcinoma for HER2 aberrations [22] and demonstrated HER2 protein overexpression (score 2+ or 3+) in 68 % and HER2 gene amplification in 42 % of their 20 tumors.